
A $12 million NIA grant will study brain energy, blood-based metabolic signals and cognitive resilience. Here is the research plan and its limits.

On October 14, 2026, UTHealth Houston announced a five-year, $12 million National Institute on Aging grant led by Rima Kaddurah-Daouk. The project will investigate how the brain’s energy supply and mitochondrial function relate to memory, mood and Alzheimer’s disease risk.
According to the UTHealth Houston announcement, mitochondria are the project’s main focus. These cellular structures are central to producing energy. Researchers will investigate how problems in mitochondrial function relate to Alzheimer’s disease and why resilience differs among people as they age.
The project brings together blood analysis and laboratory research. Its central question is how those approaches can help explain links between cellular energy and cognitive health. Genetics, lifestyle and differences between women and men are also part of the research plan.
The team plans to analyze blood from large Alzheimer’s disease and community cohorts. A cohort is a group of people included in research. Investigators will look for metabolomic signatures, or blood-based metabolic patterns, that may serve as proxies for mitochondrial health and function.
A proxy is an indirect indicator used to study something else. Here, researchers want to learn whether patterns in blood can provide useful clues about mitochondrial function. That makes the blood work a way to investigate the broader energy question rather than a separate project focused only on memory scores.
The announcement specifically describes looking for signatures in women and men. This places sex-related differences within the study’s design rather than leaving them as a question to ask after the main analysis.
UTHealth Houston says the team will conduct longitudinal analyses. This means examining how blood markers correlate with Alzheimer’s disease progression over time. Researchers will also evaluate whether those relationships differ between women and men.
This part of the plan asks a different question from whether a blood pattern is present. It asks how that pattern relates to the course of disease. Together, the planned analyses connect the search for metabolic signatures with the question of how cognitive health changes during aging.
Kaddurah-Daouk said the work aims to identify pathways through which mitochondria fail in men and women. She described the longer-term goal as informing precision-medicine approaches to Alzheimer’s prevention and treatment. In this context, the ambition is to account for biological differences rather than assume the same approach will suit everyone.
The research plan also includes cell-based systems and chemical and genetic screening. According to the announcement, these methods will be used to investigate links between mitochondrial failure and Alzheimer’s pathology, meaning the biological changes associated with the disease.
The team will screen compounds that target mitochondria. It will also examine possible drug, supplement and lifestyle approaches. These strands connect the search for blood-based signals with laboratory questions about the processes behind them.
Kaddurah-Daouk is professor and chair of UTHealth Houston’s Department of Precision Behavioral Health. Her collaborators include Matthias Arnold of Helmholtz and Russell Swerdlow of the University of Kansas. The announcement also names several other research institutions involved in the project.
The work builds on the Alzheimer Disease Metabolomics Consortium. That consortium is part of the Accelerating Medicines Partnership Program for Alzheimer’s Disease. UTHealth Houston presents the grant as an extension of this broader effort to use metabolic information to understand brain aging.
For researchers, the award provides funding to connect observations from blood with laboratory studies of cellular energy. The practical task is to work from patterns toward explanations. The project combines follow-up over time with investigations of possible biological mechanisms.
For adults over 60 who follow cognitive-health research, the announcement provides a specific set of questions to watch as future findings appear:
These questions come from the project’s stated plans. They offer a useful way to read future coverage without relying on the size of the grant or the promise of a research target.
For patients and doctors, the announcement can also provide a starting point for discussing what a brain-energy headline actually describes. Personal decisions about testing or treatment belong with a qualified care professional who can assess the individual situation.
Related reading on how scientists study brain resilience and how to interpret emerging blood-marker research provides context for following this area of cognitive-aging science.
The main limit is straightforward: this announcement reports research funding and a plan, not clinical results. It does not show that a new blood test or intervention preserves memory or prevents Alzheimer’s disease. The funding amount describes the resources committed to the work rather than the strength of an eventual finding.
The proposed blood signatures remain research proxies. The announcement does not report their diagnostic accuracy or clinical validation. It also does not establish that they can predict an individual person’s Alzheimer’s risk or future course.
The planned follow-up has a separate limit. Finding that a marker correlates with disease progression would not establish that mitochondrial dysfunction caused a person’s cognitive changes. Nor would it show that changing the marker improves health. A relationship between measurements and a useful treatment effect are different kinds of evidence.
Laboratory screening also needs to be kept in its proper place. A compound selected for investigation is a research candidate. The announcement provides no patient outcomes showing that the proposed drug, supplement or lifestyle directions are effective.
For everyday decisions, the practical guidance is to avoid treating this grant as a reason to start a mitochondrial supplement or alter medical care. The announcement supplies no specific intervention or clinical recommendation. Its mention of lifestyle identifies a subject for investigation rather than a routine for readers to follow.
This distinction matters when judging claims built around the term “mitochondrial health.” The project’s questions are specific: which patterns appear in blood and how do they relate to function and disease? A product claim should not inherit credibility simply because it uses the same biological language.
This grant matters because it supports a connected investigation of brain energy and cognitive resilience. Blood analysis may help identify patterns worth studying. Follow-up can examine their relationship with disease progression, while laboratory work can investigate possible mechanisms.
For cognitive health, the long-term value will rest on what that sequence produces: findings that hold up and explanations that guide useful research. The project gives attention to why resilience differs among people rather than treating aging as a uniform experience.
The right measure of progress is therefore the evidence that follows the award. A better understanding of cellular energy could help shape future questions about preserving cognitive function. The grant provides a structured opportunity to pursue those questions without settling them in advance.
The day-to-day task of weighing brain-energy claims belongs to readers and their care teams, while FitBrainLab makes the underlying science easier to follow. For adults 60+ uncertain about habits that support cognition, its coverage separates proposed approaches from established evidence and connects complex brain-aging research with practical understanding.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.



Build habits that support memory, focus and a curious, connected life.
Read the Blog